278
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Rapid response to avapritinib of acute myeloid leukemia with t(8;21) and KIT mutation relapse post allo-HSCT

, , , , , , & ORCID Icon show all
Pages 2247-2250 | Received 01 Dec 2021, Accepted 05 Apr 2022, Published online: 19 Apr 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (2)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.